: Mycophenolate, Immunoassay, Serum or Plasma (Qualitative)

: What This Test Measures

: Mycophenolate is a medicine used to prevent rejection after organ transplant and to treat certain autoimmune conditions. This test looks for the drug in serum or plasma, the liquid part of blood, using an immunoassay, a method that uses antibodies to detect the substance. Because it is reported qualitatively, the result is generally positive (detected) or negative (not detected) rather than a specific number.

: Why Your Care Team Might Order It

: Your provider may order this test to confirm that mycophenolate is present in your bloodstream, which can help check whether you are absorbing and taking the medication as expected. It may also be used when there is concern about missed doses, absorption problems, or unusual symptoms. Qualitative testing is used for detection rather than for fine-tuning doses.

: How the Sample Is Collected

: A blood sample is drawn from a vein, usually in your arm, and the serum or plasma is separated for testing. Timing can matter for medicine tests, so follow any instructions your care team gives about when to have your blood drawn relative to your doses. Tell your provider about all medications and supplements you take.

: What the Results Mean

: A positive result means mycophenolate was detected in the sample; a negative result means it was not detected at the test's detection limit. A single qualitative result does not show whether your dose is too high, too low, or ideal, and it cannot replace monitoring tailored to your treatment plan. Your provider will interpret results alongside your dose history, timing, and overall clinical picture.